Are you not across the very encouraging results of the pilot trial conducted in 2020?
These results have provided the platform for 2 further years of hardware and software enhancements by EMV's in-house team and the UQ. The enhanced device is now the subject of the 12-month pivotal trials at 3 leading stroke hospitals.
Its now a matter of watch this space
Ann: Trial Progressing on Target and ASA Milestone Achieved, page-18
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.98 |
Change
0.060(3.13%) |
Mkt cap ! $164.0M | |||
| Open | High | Low | Value | Volume |
| $1.92 | $2.00 | $1.92 | $19.74K | 10.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5829 | $1.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.01 | 300 | 1 |
View Market Depth
| Last trade - 11.53am 04/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |